The Egyptian Thalassaemia Association (ETA),  in celebration of this year’s International Thalassaemia Day, is organizing the 20th International Thalassaemia Day Conference to be held in Cairo on May, 1-2, 2019. Renowned international and national scientists working in the field, among which Dr. Frempong, one of the pioneers of sickle ...

  The European Medicines Agency (EMA) has published a booklet describing the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU. The booklet’s title is “From laboratory to patient: the journey of a centrally authorised medicine“ ...

At TIF we believe that well-informed patients are able to gain in-depth understanding of their condition and make purposeful decisions about their health! That being so, we are pleased to announce that registrations for the upcoming 6th class of its Thal e-Course for patients are now open! You can access the registration form here 👉 http://bit.ly/2BVkX9c    

  The Mumbai Hematology Group is organizing the 7th Thalassaemia Lunch-On Symposium on the 27th April 2019 in Mumbai, India. The Symposium will be covering several topics germane to thalassaemia, including expert sessions dedicated to the clinical management, multidisciplinary care, and springing up challenges and therapies of the disease. The meeting is ...

  The city of Dhaka, Bangladesh hosted on January 28 – 31, 2019 the “International Thalassaemia Conference 2019”, gathering researchers, doctors, and patients with thalassaemia from many countries. The aim of the Conference was to improve the overall management of the disease in Bangladesh, through the constructive exchange of views ...

Fellowship Programme DURATION: Two (2) months CANDIDATES: This fellowship is offered to 2-4 physicians per year. VENUE: Currently through the Joint Red Cell Unit, Haematology Department of the University College London NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, UK. DEADLINE FOR APPLICATION: 31st March 2019 OUR SPECIALIST TEAM: Prof John Porter, Supervisor ...

  In the studies of the late Prof Efremov[1], which included all regions of old Yugoslavia, the carrier rate of beta thalassaemia in Serbia was determined to be at least 1.2%, and, in studying the molecular epidemiology of the country, it has been established that 30% of cases are due ...